Microdose tirzepatide providers, graded

A tirzepatide microdose plan, as sellers describe it

A provider that sells microdose tirzepatide is selling a plan of smaller amounts than its weight-loss program, often under its own product name. There is no shared definition, so the amount, the form and the goal differ from one provider to the next.

Some sellers frame the plan around aging rather than weight. Read each provider's own description on its check page, and treat the marketing goal as a claim to ask about, not a finding.

10 providers with a published check sell such a plan. 1 of them pass all 4 checks; the other 7 pass 3.

Marketed wellness microdosing is not an approved indication

The two FDA-approved tirzepatide products, Mounjaro for type 2 diabetes and Zepbound for weight and sleep apnea, are injections whose labels set out dose levels the prescriber moves through. Approved dose levels do not establish a separate wellness or longevity indication.

The identified microdose plans on this list are compounded, prepared by a pharmacy without an FDA review of its safety, effectiveness or quality.

If the pitch is healthy aging, the evidence is thin. No outcome trial shows that tirzepatide extends lifespan, and Mounjaro's heart-risk indication, added on August 27, 2026, covers adults with type 2 diabetes only.

The 4 checks, read for a smaller tirzepatide plan

Licensed US pharmacy. 7 of the 10 don't name a dispensing pharmacy that shows an active license. That is the Flag behind 7 of the 9 B grades. A compounded plan is only as consistent as the pharmacy making it, fill after fill.

Prescriber reviews you first. None of the 10 skips it: each says a clinician reviews your intake before prescribing. Ask the clinician how they'll judge whether the plan is doing anything.

Price shown before signup. bmiMD, ElleS, Fridays and Lttl take a Flag. The next section covers why.

No research-only products. No provider here sells a research-use peptide. The methodology sets out what each check accepts.

Who sells microdose tirzepatide here, and in what form

With an A: Luvo Health at $194.45. With a B: AgelessRx at $159, Brightmeds (no standing price up front) and Enhance MD at $189. With a B: Fridays (no standing price up front), Goldspan Health at $216.18 and iThriveMD at $211.25. With a B: Lttl (no standing price up front). With a C: bmiMD (no standing price up front) and ElleS (no standing price up front). The figure after each name is the standing monthly price of its microdose plan.

Most plans are injections. ElleS and Goldspan Health also sell a dissolving tablet or sublingual version. No FDA-approved tirzepatide comes in a form you take by mouth, so that version rests entirely on the pharmacy that makes it.

Signs a microdose tirzepatide offer needs a second look

It ships without a prescriber. "Research use" tirzepatide sold in small vials skips the clinician and the dispensing pharmacy. Those sellers aren't on this list, and a small amount doesn't make them care.

It sits next to retatrutide. If a catalog lists retatrutide beside a tirzepatide plan, read on. Retatrutide is investigational, not FDA-approved, and FDA says it can't legally be compounded. A provider selling it would carry a research-only Flag.

It renews on a long period you didn't notice. A plan billed every 2 months or longer charges more at once than a monthly one. Read the renewal terms before you enter a card number.

It promises results. The reviewed evidence does not establish energy or anti-aging benefits from a marketed microdose program. Ask the provider where that claim comes from.

What to raise with the prescriber

A smaller amount is still the same drug, with the same label warnings. The Zepbound and Mounjaro labels carry a boxed warning about thyroid C-cell tumors seen in rodents, and they list pancreatitis and gallbladder disease among their warnings. Mention any history of those at intake.

List everything else you take, supplements included, and ask how the plan will be reviewed. A good answer names a point at which you and the prescriber decide whether to continue.

How microdose tirzepatide plans bill

Standing monthly figures run from $159 at AgelessRx to $216.18 at Goldspan Health, and the median is $194.45. A year runs $1,908 to $2,594.16 before any visit or lab fee.

The billing period is where these plans differ most. Luvo Health and Goldspan Health charge every 28 days or 4 weeks, which makes a 28-day charge interval.

AgelessRx's price is billed every 2 months. The card shows the monthly share, but each charge on your statement covers the full period.

AgelessRx and Luvo Health advertise a lower first-period figure. The list shows the standing price instead, since that is what month 2 costs.

bmiMD, Brightmeds, ElleS, Fridays and 1 more keep its microdose price behind the intake questions, so ask for it in writing.